July 2019
Volume 60, Issue 9
Free
ARVO Annual Meeting Abstract  |   July 2019
Imaging of Retinal Oxygen Delivery and Metabolism in Diabetic Retinopathy
Author Affiliations & Notes
  • Mahnaz Shahidi
    Ophthalmology, University of Southern California, Los Angeles, California, United States
  • Sophie Leahy
    Ophthalmology, University of Southern California, Los Angeles, California, United States
  • Selin L Auvazian
    Ophthalmology, University of Southern California, Los Angeles, California, United States
  • Ou Tan
    Ophthalmology, Oregon Health & Science University, Portland, Oregon, United States
  • David Huang
    Ophthalmology, Oregon Health & Science University, Portland, Oregon, United States
  • Amir H. Kashani
    Ophthalmology, University of Southern California, Los Angeles, California, United States
  • Andrew A Moshfeghi
    Ophthalmology, University of Southern California, Los Angeles, California, United States
  • Hossein Ameri
    Ophthalmology, University of Southern California, Los Angeles, California, United States
  • Norman P Blair
    Ophthalmology & Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, United States
  • Footnotes
    Commercial Relationships   Mahnaz Shahidi, None; Sophie Leahy, None; Selin Auvazian, None; Ou Tan, Optovue (P); David Huang, Optovue (F), Optovue (I), Optovue (P), Optovue (R); Amir Kashani, None; Andrew Moshfeghi, None; Hossein Ameri, None; Norman Blair, None
  • Footnotes
    Support  NIH grants DK104393 and EY029220 and Research to Prevent Blindness.
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 6078. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mahnaz Shahidi, Sophie Leahy, Selin L Auvazian, Ou Tan, David Huang, Amir H. Kashani, Andrew A Moshfeghi, Hossein Ameri, Norman P Blair; Imaging of Retinal Oxygen Delivery and Metabolism in Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci. 2019;60(9):6078. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Diabetic retinopathy (DR) is a major complication of diabetes and the leading cause of vision loss in working age adults. With progression of DR, retinal vascular abnormalities and tissue hypoxia are thought to contribute to the development of vision-threatening pathologies. Since there are no available methods to measure retinal tissue oxygenation in human subjects, assessment of the rate of oxygen metabolism (MO2) can provide essential information about the ability of cells to generate energy and perform visual processing. The purpose of the current study was to test the hypothesis that MO2 is impaired at progressive stages of DR, concurrent with a reduction in the rate of oxygen delivery (DO2) and elevation in the fraction of oxygen extraction (OEF).

Methods : The study was performed in 51 subjects, categorized in 4 groups: non-diabetic (N=14), no DR (N=9), non-proliferative DR (NPDR) (N=18), and treated proliferative DR (PDR) (N=10). Dual wavelength oximetry and Doppler OCT imaging were performed to measure retinal vascular oxygen saturation and total retinal blood flow, respectively. DO2 and MO2 were derived based on measurements of oxygen saturation and blood flow. OEF was calculated as the ratio of MO2 to DO2. General linear models were generated to compare oxygen metrics between non-diabetic and each DR group.

Results : Mean age was not statistically different among the 4 groups (P=0.14). In the non-diabetic group, DO2, MO2, and OEF were 8.90±2.90 uLO2/min, 3.50±1.05 uLO2/min, and 0.40±0.08, respectively. DO2 was lower in NPDR (β=-1.91 uLO2/min; P=0.05) and PDR (β=-3.62 uLO2/min; P=0.002) compared to the non-diabetic group. Likewise, MO2 was lower in NPDR (β=-0.85 uLO2/min; P=0.05) and PDR (β=-1.45 uLO2/min; P=0.005). OEF was not significantly different between non-diabetic and DR groups (P>0.45). With optimal binning of MO2 with respect to DR stage, all non-diabetic and no DR subjects had MO2>1.96 uLO2/min. In contrast, 11/18 (61%) and 4/10 (40%) of NPDR and PDR subjects had MO2<1.96 uLO2/min. MO2 was linearly related to DO2 (R=0.85; P<0.001) and OEF (R=0.47; P<0.001), while OEF and DO2 were not correlated (R=-0.01; P=0.94).

Conclusions : The results demonstrated reductions of DO2 and MO2 concurrent with unchanged OEF in NPDR and PDR. Further studies are needed to investigate the coupling of these oxygen metrics to help advance the understanding of DR pathophysiology.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×